Filing Details

Accession Number:
0000908834-24-000179
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-07-11 17:15:45
Reporting Period:
2024-07-09
Accepted Time:
2024-07-11 17:15:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
926617 Aspira Women's Health Inc. AWH In Vitro & In Vivo Diagnostic Substances (2835) 330595156
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1021412 W Jack Schuler Po Box 531
Lake Bluff IL 60044
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-07-09 6,536 $0.00 6,536 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant (Right to Buy) Acquisiton 2024-07-09 6,536 $0.00 6,536 $2.25
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,536 2024-07-09 2027-07-09 No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,912,156 Indirect By Jack W. Schuler Living Trust
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Warrant (Right to Buy) $4.13 2024-07-26 2029-07-26 28,500 28,500 Indirect
Common Stock Warrant (Right to Buy) $4.13 2022-08-25 2029-01-26 8,888 8,888 Indirect
Expiration Date Amount Remaning Holdings Nature of Ownership
2029-07-26 28,500 28,500 Indirect
2029-01-26 8,888 8,888 Indirect
Footnotes
  1. Each share of common stock was purchased together with one warrant to purchase one share of common stock at a price of $1.53.
  2. Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust (the "Living Trust"), and in such capacity may be deemed to beneficially own the securities held by the Living Trust.